Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hepatitis B 2 Carcinoma, Hepatocellular 2 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Hepatitis B, Chronic 1 Arthritis, Rheumatoid 1

Interventions

Vinorelbine 3 Gemcitabine 3 Ifosfamide 2 Cyclophosphamide 2 zanubrutinib 1 treosulfan 1 plerixafor 1 pegylated granulocyte colony-stimulating factor 1 obinutuzumab 1 ibritumomab tiuxetan 1 fludarabine 1 entecavir 1 Thiotepa 1 Rituximab 1 Ice 1 Guanosine Diphosphate 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 EPOCH protocol 1 Drug Therapy 1 Cytarabine 1 CVAD protocol 1 1-(1-glycero)dodeca-1,3,5,7,9-pentaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Lymphoma, Non-Hodgkin × entecavir × Clear all

NCT00926757 2013-05-29

HBVNHL

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed

Hepatitis B, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡